Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children

Journal of the Formosan Medical Association

Volumn 102, Issue 6, 2003, Pages 387-393

  Lin, Ming Tsan ^a,b   Lin, Kai Hsin ^c   Lin, Dong Tsamn ^c   Yang, Rong Sen ^c   Wu, Chen Tu ^c   Lu, Meng Yao ^c   Hung, Iou Jih ^d   Yang, Chao Ping ^d   Chang, Tai Tsung ^e   Shu, San Ging ^f   Chen, Rong Long ^g   Hsiao, Tyh Chen ^d   Chang, Wan Hui ^h   Lin, Kuo Sin ^h  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g Tz'u Chi Hospital   (Taiwan)

^h Childhood Cancer Foundation   (Taiwan)

Author keywords

Antineoplastic combined chemotherapy protocols; Necrosis; Osteosarcoma; Salvage therapy

Indexed keywords

AMINOTRANSFERASE; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; ANEMIA; ARTICLE; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LEUKOPENIA; LIMB SALVAGE; LIVER DYSFUNCTION; MALE; MEDICAL ASSESSMENT; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OSTEOSARCOMA; POSTOPERATIVE CARE; PREOPERATIVE CARE; TAIWAN; THROMBOCYTOPENIA; TREATMENT OUTCOME; BONE TUMOR; CLINICAL TRIAL; LIMB; MULTICENTER STUDY; NONPARAMETRIC TEST; PRESCHOOL CHILD; SURVIVAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; EXTREMITIES; FEMALE; HUMANS; MALE; METHOTREXATE; OSTEOSARCOMA; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME;

EID: 0142168039     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-6.
2. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma-The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979;43:2163-77.
3. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30.
4. Simone JV, Meyer WH, Link MP: Osteosarcoma: good news despite crude tools. J Clin Oncol 1992;10:1-2.
5. Ferguson WS, Goorin AM: Current treatment of osteosarcoma. Cancer Invest 2001;19:292-315.
6. Meyers PA, Heller G, Healay JH, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5-15.
7. Davis AM, Bell RS, Goodwin PJ: Prognostic factors in osteosarcoma: A critical review. J Clin Oncol 1994;12:423-31.
8. Picci P, Sangiorgi L, Rougraff BT, et al: Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 1994;12:2699-705.
9. Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84.
10. Winkler K, Beron g, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988;6:329-37.
11. Huvos AG, Rosen G, Marcove RC: Primary osteogenic sarcoma. Pathologic aspects in 20 patients aftr treatment with chemotherapy, en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 1977;101:14-8.
12. Bacci G, Ferrai S, Bertoni F, et al: Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Instituto Ortopedico Rizzoli according to the Instituto Orthopedico Rizzoli/Osteosarcoma-2 protocol: An updated report. J Clin Oncol 2000;18:4016-27.
13. Ferrari S, Mercuri M, Picci P, et al: Nonmetastatic osteosarcoma of the extremity: Results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Tumori 1999;85:458-64.
14. Bacci G, Picci P, Ruggieri P, et al: Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Instituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990; 65:2539-53.
15. Hryniuk W, Bush H: Importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984;2:1281-8.
16. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 1981;47:207-14.
17. Marcove RC, Mike v, Hajek JV, et al: Osteogenic sarcoma under the age of twenty-one: A review of one hundred forty-five operative cases. J Bone Joint Surg 1970;52:411-23.
18. Rosen G, Nirenberg A: Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe. Cancer Treat Rep 1982; 66:1687-97.
19. Nachman J, Simon MA, Dean L, et al: Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol 1987;5:1185-90.
20. Meyers PA, Garlick R, Heller G, et al: Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 1998;16: 2452-8.
21. Bramwell VHC, Burgers M, Sneath R, et al: A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992;10:1579-91.
22. Souhami RL, Craft AW, van der Eijken JW, et al: Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350:911-7.
23. Bacci G, Ferrari S, Longhi A, et al: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: Long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemotherapy 2001;13:93-99.
24. Bacci G, Ferrari S, Mercuri M, et al: Neoadjuvant chemotherapy for extremity osteosarcoma. Preliminary result of the Rizzoli's 4th study. Acta Oncol 1998;37:41-8.
25. Philip T, Iliescu C, Demaille MC, et al: High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]- doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study. Ann Oncol 1999;10:1065-71.
26. Fuchs N, Bielack SS, Epler D, et al: Long-term results of the co-operative German - Austrian - Swiss osteosarcoma study group's protocol COSS-86 of the intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998;9:893-9.
27. Harris MB, Cantor AB, Goorin AM, et al: Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease verus patients previously untreated: A Pediatric Oncology Group study. Med Pediatr Oncol 1995;24:87-92.